News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:
Showing 800 articles
Image
News placeholder image
02.11.2021

It's time to level up health

Debbie Horne, Senior Policy Officer at Diabetes UK, reflects on what the Spending Review omitted and what...
Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk